Safety and Immunogenicity of Improved Shigella O-Specific Polysaccharide-Protein Conjugate Vaccines in Adults in Israel

類似資料

• Erratum to ‘Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children’ [Vaccine 28 (2010) 2231–2235]
  著者:: Passwell, Justen H., 等
  出版事項: (2019)
• Age-related efficacy of Shigella O-specific-polysaccharide conjugates in 1 to 4 year-old Israeli children
  著者:: Passwell, Justen H., 等
  出版事項: (2010)
• Treatment with Succinic Anhydride Improves the Immunogenicity of Shigella flexneri Type 2a O-Specific Polysaccharide–Protein Conjugates in Mice
  著者:: Pavliakova, Danka, 等
  出版事項: (1999)
• O-Specific polysaccharide conjugate vaccine-induced IgG antibodies prevent invasion of Shigella into Caco-2 cells and may be curative
  著者:: Chowers, Yehuda, 等
  出版事項: (2007)
• Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid.
  著者:: Chu, C Y, 等
  出版事項: (1991)